# Tailored Messaging for CRC Screening

> **NCT03310892** · NA · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 600 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BEHAVIORAL:** Generic message
- **BEHAVIORAL:** Tailored message

## Key facts

- **NCT ID:** NCT03310892
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-09
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-10-01
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2023-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03310892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03310892, "Tailored Messaging for CRC Screening". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03310892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*